非典型抗精神病药物利培酮的药物基因组学研究进展

Progress in pharmacogenomics of atypical antipsychotic risperidone

ES评分 0

DOI
刊名
Journal of International Psychiatry
年,卷(期) 2021, 48(2)
作者
作者单位

济宁医学院精神卫生学院 ;
济宁市精神病防治院 ;

摘要
利培酮是一种精神科常用的、有效的非典型抗精神病药,具有疗效好、副作用少、耐受性好等特点。但是,利培酮的药物反应存在显著的个体间差异。遗传因素在利培酮药物反应个体差异性中起到重要作用。药物基因组学或许可以用于指导临床合理用药,提高患者服药依从性,减少药物不良反应,达到优化利培酮治疗效果的目的。本文通过对代谢、转运、神经递质受体等基因多态性与利培酮药物反应之间的关系进行总结分析,为下一步开展利培酮个体化用药的研究提供参考。
Abstract
Risperidone is a common and effective atypical antipsychotics in psychiatric department with the characteristics of good curative effect, few side effects and good tolerance. However, there were significant individual differences in risperidone drug reactions. Genetic factors play an important role in the individual differences of risperidone response. Pharmacogenomics may be used to guide clinical rational drug use, improve patients medication compliance, reduce adverse drug reactions, and achieve the purpose of optimizing the therapeutic effect of risperidone. Here, we summarized and analyzed the relationship between gene polymorphism of metabolism, transport, neurotransmitter receptor and risperidone drug reaction, and provided reference for the further study of risperidone individualized medication.
关键词
非典型抗精神病药;利培酮;药物反应;药物基因组学;基因多态性
KeyWord
Atypical antipsychotics; Risperidone; Drug reaction; Pharmacogenomics; Gene Polymorphism
基金项目
页码 200-202
  • 参考文献
  • 相关文献
  • 引用本文

罗扬扬,翟晓丽,刘霞,王秋玲,姚宁,翟金国,郁昊,陈敏*. 非典型抗精神病药物利培酮的药物基因组学研究进展 [J]. 国际精神病学杂志. 2021; 48; (2). 200 - 202.

  • 文献评论

相关学者

相关机构